Evidence map›Paper›PMID 41038839›Full record

ArticleNPJ systems biology and applications2025

Machine learning framework to extract physicochemical features of B-cell epitopes recognized by a cross-reactive antibody.

Simranjit Grewal, Uwa Iyamu, Daniel Ferrer Vinals, Catherine J Mitran, Nidhi Hegde, Stephanie K Yanow

Abstract read
In one paragraph

Article in NPJ systems biology and applications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Simranjit GrewalDepartment of Medical Microbiology and Immunology, University of Alberta, Edmonton, AB, Canada.
Uwa IyamuSchool of Public Health, University of Alberta, Edmonton, AB, Canada.
Daniel Ferrer VinalsSchool of Public Health, University of Alberta, Edmonton, AB, Canada.
Catherine J MitranSchool of Public Health, University of Alberta, Edmonton, AB, Canada.
Nidhi HegdeDepartment of Computing Science, University of Alberta, Edmonton, AB, Canada.
Stephanie K YanowDepartment of Medical Microbiology and Immunology, University of Alberta, Edmonton, AB, Canada. Yanow@ualberta.ca.

Funding

Exploiting cross-reactive, conserved epitopes in Plasmodium vivax to develop a vaccine against falciparum placental malaria.R01AI150944 · NIAID · UNIVERSITY OF ALBERTA · PI YANOW, STEPHANIE · 2020 to 2025
$1.9M
CIHR 168944National Institute of Allergy and Infectious Diseases of the National Institutes of Health R01AI150944Natural Sciences and Engineering Research Council of Canada RGPIN-2017-04176NIAID NIH HHS R01 AI150944
6 · The paper itself

Abstract

During infection with Plasmodium falciparum in pregnancy, parasites express a unique virulence factor, VAR2CSA, that mediates binding of infected red blood cells to the placenta. A major goal in designing vaccines to protect pregnant women from malaria is to elicit antibodies to VAR2CSA. The challenge is that VAR2CSA is highly polymorphic and identifying conserved epitopes is essential to elicit strain-transcending immunity. Unexpectedly, a mouse monoclonal antibody, 3D10, raised against region II of the unrelated Duffy binding protein from P. vivax (DBPII) cross-reacts with diverse alleles of VAR2CSA in vitro, suggesting that epitopes may be shared across this family of 'Duffy binding-like' (DBL) proteins. Peptide arrays spanning four DBL proteins from two Plasmodium spp, including two alleles of VAR2CSA, DBPII, and PvEBP2 (as a negative control), were screened with 3D10 but the data were too complex to manually identify common epitope sequences. As such, we designed a machine learning framework to analyse the array data. We applied decision trees to extract features correlated to 3D10 binding and evaluated the model on an independent dataset for a rodent Plasmodium DBL protein (PcDBP). Next, we analysed patterns of the features predicted by the model to be strongly associated with 3D10 binding and designed mutant peptides to test complex sequence motifs. Features associated with 3D10 reactivity were mapped onto predicted 3D structures of Plasmodium proteins and validated based on 3D10 reactivity to the recombinant antigens. While the array data identified certain linear epitopes, the framework predicted other epitopes to be conformational. This was demonstrated with PcDBP; as predicted by the model, no linear peptides reacted strongly with 3D10, yet the folded protein was recognized by the antibody in a conformation-dependent manner. With this approach, peptide array data can be mined to extract physicochemical properties of epitopes recognized by cross-reactive antibodies.

Indexed as

Antibodies, ProtozoanEpitopes, B-LymphocyteMachine LearningAnimalsAntigens, ProtozoanCross ReactionsFemaleHumansMalaria, FalciparumMicePlasmodium falciparumProtozoan ProteinsAntibodies, ProtozoanAntigens, ProtozoanEpitopes, B-LymphocyteProtozoan ProteinsVAR2CSA protein, Plasmodium falciparum

Identifiers

PMID41038839
PMCPMC12491407

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.